Susquehanna International Group, LLP Sorrento Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.74 - $1.83 $200,540 - $495,930	-271,000 Reduced 26.84%	738,700 $657,000
Q3 2022 Nov 14, 2022	SELL	$1.51 - $2.88 $393,959 - $751,392	-260,900 Reduced 20.53%	1,009,700 $1.59 Million
Q2 2022 Aug 15, 2022	SELL	$1.24 - $2.33 $238,080 - $447,360	-192,000 Reduced 13.13%	1,270,600 $2.55 Million
Q1 2022 May 16, 2022	SELL	$2.0 - $4.9 $698,800 - $1.71 Million	-349,400 Reduced 19.28%	1,462,600 $3.41 Million
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $787,710 - $1.22 Million	-169,400 Reduced 8.55%	1,812,000 $8.43 Million
Q3 2021 Nov 15, 2021	SELL	$7.41 - $10.99 $1.07 Million - $1.59 Million	-144,600 Reduced 6.8%	1,981,400 $15.1 Million
Q2 2021 Aug 11, 2021	BUY	$6.35 - $10.0 $1.86 Million - $2.93 Million	293,000 Added 15.98%	2,126,000 $20.6 Million
Q1 2021 May 17, 2021	BUY	$7.03 - $16.51 $892,810 - $2.1 Million	127,000 Added 7.44%	1,833,000 $15.2 Million
Q4 2020 Feb 16, 2021	SELL	$5.76 - $11.95 $9.7 Million - $20.1 Million	-1,684,300 Reduced 49.68%	1,706,000 $11.6 Million
Q3 2020 Nov 16, 2020	BUY	$6.17 - $18.82 $14.2 Million - $43.3 Million	2,298,100 Added 210.41%	3,390,300 $37.8 Million
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $1.49 Million - $5.82 Million	860,600 Added 371.59%	1,092,200 $6.86 Million
Q1 2020 May 15, 2020	BUY	$1.57 - $4.76 $301,440 - $913,920	192,000 Added 484.85%	231,600 $426,000
Q4 2019 Feb 14, 2020	SELL	$1.45 - $4.17 $80,765 - $232,269	-55,700 Reduced 58.45%	39,600 $134,000
Q3 2019 Nov 14, 2019	SELL	$2.05 - $2.69 $86,099 - $112,980	-42,000 Reduced 30.59%	95,300 $204,000
Q2 2019 Aug 14, 2019	BUY	$2.67 - $4.38 $48,594 - $79,716	18,200 Added 15.28%	137,300 $367,000
Q1 2019 May 15, 2019	BUY	$1.86 - $5.94 $156,798 - $500,742	84,300 Added 242.24%	119,100 $566,000
Q4 2018 Feb 14, 2019	BUY	$2.01 - $4.24 $32,762 - $69,112	16,300 Added 88.11%	34,800 $84,000
Q3 2018 Nov 14, 2018	SELL	$4.22 - $7.5 $762,554 - $1.36 Million	-180,700 Reduced 90.71%	18,500 $81,000
Q2 2018 Aug 14, 2018	BUY	$4.75 - $8.0 $858,800 - $1.45 Million	180,800 Added 982.61%	199,200 $1.43 Million
Q1 2018 May 15, 2018	BUY	$4.5 - $9.95 $82,800 - $183,080	18,400 New	18,400 $95,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account